0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-36P9168
Home | Market Reports | Health| Nursing
Global Biological Indicators Market Insights and Forecast to 2028
BUY CHAPTERS

Biological Indicators- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-36P9168
Report
August 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biological Indicators- Market Size

The global market for Biological Indicators was estimated to be worth US$ 411 million in 2024 and is forecast to a readjusted size of US$ 610 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.

Biological Indicators- Market

Biological Indicators- Market

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biological Indicators by region & country, by Type, and by Application.
The Biological Indicators market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
Market Segmentation

Scope of Biological Indicators- Market Report

Report Metric Details
Report Name Biological Indicators- Market
Forecasted market size in 2031 US$ 610 million
CAGR 5.9%
Forecasted years 2025 - 2031
Segment by Type
  • Self-Contained Biological Indicator
  • Biological Indicator Strip
Segment by Application
  • Hospital
  • Pharma Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy, Advanced Sterilization, Bag Health Care, Terragene, Andersen, GKE
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biological Indicators company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biological Indicators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biological Indicators in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biological Indicators- Market size in 2031?

Ans: The Biological Indicators- Market size in 2031 will be US$ 610 million.

What is the market share of major companies in Biological Indicators- Market?

Ans: Global top five manufacturers hold a share over 65%.

What is the Biological Indicators- Market share by region?

Ans: North America is the largest market, with a share nearly 55%.

Who are the main players in the Biological Indicators- Market report?

Ans: The main players in the Biological Indicators- Market are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy, Advanced Sterilization, Bag Health Care, Terragene, Andersen, GKE

What are the Application segmentation covered in the Biological Indicators- Market report?

Ans: The Applications covered in the Biological Indicators- Market report are Hospital, Pharma Companies, Others

What are the Type segmentation covered in the Biological Indicators- Market report?

Ans: The Types covered in the Biological Indicators- Market report are Self-Contained Biological Indicator, Biological Indicator Strip

1 Market Overview
1.1 Biological Indicators Product Introduction
1.2 Global Biological Indicators Market Size Forecast (2020-2031)
1.3 Biological Indicators Market Trends & Drivers
1.3.1 Biological Indicators Industry Trends
1.3.2 Biological Indicators Market Drivers & Opportunity
1.3.3 Biological Indicators Market Challenges
1.3.4 Biological Indicators Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biological Indicators Players Revenue Ranking (2024)
2.2 Global Biological Indicators Revenue by Company (2020-2025)
2.3 Key Companies Biological Indicators Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biological Indicators Product Offered
2.5 Key Companies Time to Begin Mass Production of Biological Indicators
2.6 Biological Indicators Market Competitive Analysis
2.6.1 Biological Indicators Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Biological Indicators Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Self-Contained Biological Indicator
3.1.2 Biological Indicator Strip
3.2 Global Biological Indicators Sales Value by Type
3.2.1 Global Biological Indicators Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Biological Indicators Sales Value, by Type (2020-2031)
3.2.3 Global Biological Indicators Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharma Companies
4.1.3 Others
4.2 Global Biological Indicators Sales Value by Application
4.2.1 Global Biological Indicators Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Biological Indicators Sales Value, by Application (2020-2031)
4.2.3 Global Biological Indicators Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Biological Indicators Sales Value by Region
5.1.1 Global Biological Indicators Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Biological Indicators Sales Value by Region (2020-2025)
5.1.3 Global Biological Indicators Sales Value by Region (2026-2031)
5.1.4 Global Biological Indicators Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Biological Indicators Sales Value, 2020-2031
5.2.2 North America Biological Indicators Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Biological Indicators Sales Value, 2020-2031
5.3.2 Europe Biological Indicators Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Biological Indicators Sales Value, 2020-2031
5.4.2 Asia Pacific Biological Indicators Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Biological Indicators Sales Value, 2020-2031
5.5.2 South America Biological Indicators Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biological Indicators Sales Value, 2020-2031
5.6.2 Middle East & Africa Biological Indicators Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biological Indicators Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Biological Indicators Sales Value, 2020-2031
6.3 United States
6.3.1 United States Biological Indicators Sales Value, 2020-2031
6.3.2 United States Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Biological Indicators Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Biological Indicators Sales Value, 2020-2031
6.4.2 Europe Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Biological Indicators Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Biological Indicators Sales Value, 2020-2031
6.5.2 China Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.5.3 China Biological Indicators Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Biological Indicators Sales Value, 2020-2031
6.6.2 Japan Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Biological Indicators Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Biological Indicators Sales Value, 2020-2031
6.7.2 South Korea Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Biological Indicators Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Biological Indicators Sales Value, 2020-2031
6.8.2 Southeast Asia Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Biological Indicators Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Biological Indicators Sales Value, 2020-2031
6.9.2 India Biological Indicators Sales Value by Type (%), 2024 VS 2031
6.9.3 India Biological Indicators Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 3M
7.1.1 3M Profile
7.1.2 3M Main Business
7.1.3 3M Biological Indicators Products, Services and Solutions
7.1.4 3M Biological Indicators Revenue (US$ Million) & (2020-2025)
7.1.5 3M Recent Developments
7.2 Getinge Group
7.2.1 Getinge Group Profile
7.2.2 Getinge Group Main Business
7.2.3 Getinge Group Biological Indicators Products, Services and Solutions
7.2.4 Getinge Group Biological Indicators Revenue (US$ Million) & (2020-2025)
7.2.5 Getinge Group Recent Developments
7.3 Cantel Medical
7.3.1 Cantel Medical Profile
7.3.2 Cantel Medical Main Business
7.3.3 Cantel Medical Biological Indicators Products, Services and Solutions
7.3.4 Cantel Medical Biological Indicators Revenue (US$ Million) & (2020-2025)
7.3.5 Cantel Medical Recent Developments
7.4 Mesa Laboratories
7.4.1 Mesa Laboratories Profile
7.4.2 Mesa Laboratories Main Business
7.4.3 Mesa Laboratories Biological Indicators Products, Services and Solutions
7.4.4 Mesa Laboratories Biological Indicators Revenue (US$ Million) & (2020-2025)
7.4.5 Mesa Laboratories Recent Developments
7.5 Steris
7.5.1 Steris Profile
7.5.2 Steris Main Business
7.5.3 Steris Biological Indicators Products, Services and Solutions
7.5.4 Steris Biological Indicators Revenue (US$ Million) & (2020-2025)
7.5.5 Steris Recent Developments
7.6 Fuze Medical
7.6.1 Fuze Medical Profile
7.6.2 Fuze Medical Main Business
7.6.3 Fuze Medical Biological Indicators Products, Services and Solutions
7.6.4 Fuze Medical Biological Indicators Revenue (US$ Million) & (2020-2025)
7.6.5 Fuze Medical Recent Developments
7.7 Matachana
7.7.1 Matachana Profile
7.7.2 Matachana Main Business
7.7.3 Matachana Biological Indicators Products, Services and Solutions
7.7.4 Matachana Biological Indicators Revenue (US$ Million) & (2020-2025)
7.7.5 Matachana Recent Developments
7.8 Hu-Friedy
7.8.1 Hu-Friedy Profile
7.8.2 Hu-Friedy Main Business
7.8.3 Hu-Friedy Biological Indicators Products, Services and Solutions
7.8.4 Hu-Friedy Biological Indicators Revenue (US$ Million) & (2020-2025)
7.8.5 Hu-Friedy Recent Developments
7.9 Advanced Sterilization
7.9.1 Advanced Sterilization Profile
7.9.2 Advanced Sterilization Main Business
7.9.3 Advanced Sterilization Biological Indicators Products, Services and Solutions
7.9.4 Advanced Sterilization Biological Indicators Revenue (US$ Million) & (2020-2025)
7.9.5 Advanced Sterilization Recent Developments
7.10 Bag Health Care
7.10.1 Bag Health Care Profile
7.10.2 Bag Health Care Main Business
7.10.3 Bag Health Care Biological Indicators Products, Services and Solutions
7.10.4 Bag Health Care Biological Indicators Revenue (US$ Million) & (2020-2025)
7.10.5 Bag Health Care Recent Developments
7.11 Terragene
7.11.1 Terragene Profile
7.11.2 Terragene Main Business
7.11.3 Terragene Biological Indicators Products, Services and Solutions
7.11.4 Terragene Biological Indicators Revenue (US$ Million) & (2020-2025)
7.11.5 Terragene Recent Developments
7.12 Andersen
7.12.1 Andersen Profile
7.12.2 Andersen Main Business
7.12.3 Andersen Biological Indicators Products, Services and Solutions
7.12.4 Andersen Biological Indicators Revenue (US$ Million) & (2020-2025)
7.12.5 Andersen Recent Developments
7.13 GKE
7.13.1 GKE Profile
7.13.2 GKE Main Business
7.13.3 GKE Biological Indicators Products, Services and Solutions
7.13.4 GKE Biological Indicators Revenue (US$ Million) & (2020-2025)
7.13.5 GKE Recent Developments
8 Industry Chain Analysis
8.1 Biological Indicators Industrial Chain
8.2 Biological Indicators Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biological Indicators Sales Model
8.5.2 Sales Channel
8.5.3 Biological Indicators Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Biological Indicators Market Trends
 Table 2. Biological Indicators Market Drivers & Opportunity
 Table 3. Biological Indicators Market Challenges
 Table 4. Biological Indicators Market Restraints
 Table 5. Global Biological Indicators Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Biological Indicators Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Biological Indicators Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Biological Indicators Product Type
 Table 9. Key Companies Time to Begin Mass Production of Biological Indicators
 Table 10. Global Biological Indicators Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Biological Indicators Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Biological Indicators Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Biological Indicators Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Biological Indicators Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Biological Indicators Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Biological Indicators Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Biological Indicators Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Biological Indicators Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Biological Indicators Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Biological Indicators Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Biological Indicators Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Biological Indicators Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Biological Indicators Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Biological Indicators Sales Value by Region (2020-2025) & (%)
 Table 27. Global Biological Indicators Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Biological Indicators Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Biological Indicators Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Biological Indicators Sales Value, (2026-2031) & (US$ Million)
 Table 31. 3M Basic Information List
 Table 32. 3M Description and Business Overview
 Table 33. 3M Biological Indicators Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Biological Indicators Business of 3M (2020-2025)
 Table 35. 3M Recent Developments
 Table 36. Getinge Group Basic Information List
 Table 37. Getinge Group Description and Business Overview
 Table 38. Getinge Group Biological Indicators Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Biological Indicators Business of Getinge Group (2020-2025)
 Table 40. Getinge Group Recent Developments
 Table 41. Cantel Medical Basic Information List
 Table 42. Cantel Medical Description and Business Overview
 Table 43. Cantel Medical Biological Indicators Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Biological Indicators Business of Cantel Medical (2020-2025)
 Table 45. Cantel Medical Recent Developments
 Table 46. Mesa Laboratories Basic Information List
 Table 47. Mesa Laboratories Description and Business Overview
 Table 48. Mesa Laboratories Biological Indicators Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Biological Indicators Business of Mesa Laboratories (2020-2025)
 Table 50. Mesa Laboratories Recent Developments
 Table 51. Steris Basic Information List
 Table 52. Steris Description and Business Overview
 Table 53. Steris Biological Indicators Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Biological Indicators Business of Steris (2020-2025)
 Table 55. Steris Recent Developments
 Table 56. Fuze Medical Basic Information List
 Table 57. Fuze Medical Description and Business Overview
 Table 58. Fuze Medical Biological Indicators Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Biological Indicators Business of Fuze Medical (2020-2025)
 Table 60. Fuze Medical Recent Developments
 Table 61. Matachana Basic Information List
 Table 62. Matachana Description and Business Overview
 Table 63. Matachana Biological Indicators Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Biological Indicators Business of Matachana (2020-2025)
 Table 65. Matachana Recent Developments
 Table 66. Hu-Friedy Basic Information List
 Table 67. Hu-Friedy Description and Business Overview
 Table 68. Hu-Friedy Biological Indicators Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Biological Indicators Business of Hu-Friedy (2020-2025)
 Table 70. Hu-Friedy Recent Developments
 Table 71. Advanced Sterilization Basic Information List
 Table 72. Advanced Sterilization Description and Business Overview
 Table 73. Advanced Sterilization Biological Indicators Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Biological Indicators Business of Advanced Sterilization (2020-2025)
 Table 75. Advanced Sterilization Recent Developments
 Table 76. Bag Health Care Basic Information List
 Table 77. Bag Health Care Description and Business Overview
 Table 78. Bag Health Care Biological Indicators Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Biological Indicators Business of Bag Health Care (2020-2025)
 Table 80. Bag Health Care Recent Developments
 Table 81. Terragene Basic Information List
 Table 82. Terragene Description and Business Overview
 Table 83. Terragene Biological Indicators Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Biological Indicators Business of Terragene (2020-2025)
 Table 85. Terragene Recent Developments
 Table 86. Andersen Basic Information List
 Table 87. Andersen Description and Business Overview
 Table 88. Andersen Biological Indicators Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Biological Indicators Business of Andersen (2020-2025)
 Table 90. Andersen Recent Developments
 Table 91. GKE Basic Information List
 Table 92. GKE Description and Business Overview
 Table 93. GKE Biological Indicators Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Biological Indicators Business of GKE (2020-2025)
 Table 95. GKE Recent Developments
 Table 96. Key Raw Materials Lists
 Table 97. Raw Materials Key Suppliers Lists
 Table 98. Biological Indicators Downstream Customers
 Table 99. Biological Indicators Distributors List
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Biological Indicators Product Picture
 Figure 2. Global Biological Indicators Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Biological Indicators Sales Value (2020-2031) & (US$ Million)
 Figure 4. Biological Indicators Report Years Considered
 Figure 5. Global Biological Indicators Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Biological Indicators Revenue in 2024
 Figure 7. Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Self-Contained Biological Indicator Picture
 Figure 9. Biological Indicator Strip Picture
 Figure 10. Global Biological Indicators Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Biological Indicators Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Hospital
 Figure 13. Product Picture of Pharma Companies
 Figure 14. Product Picture of Others
 Figure 15. Global Biological Indicators Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 16. Global Biological Indicators Sales Value Market Share by Application, 2024 & 2031
 Figure 17. North America Biological Indicators Sales Value (2020-2031) & (US$ Million)
 Figure 18. North America Biological Indicators Sales Value by Country (%), 2024 VS 2031
 Figure 19. Europe Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 20. Europe Biological Indicators Sales Value by Country (%), 2024 VS 2031
 Figure 21. Asia Pacific Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 22. Asia Pacific Biological Indicators Sales Value by Region (%), 2024 VS 2031
 Figure 23. South America Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 24. South America Biological Indicators Sales Value by Country (%), 2024 VS 2031
 Figure 25. Middle East & Africa Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 26. Middle East & Africa Biological Indicators Sales Value by Country (%), 2024 VS 2031
 Figure 27. Key Countries/Regions Biological Indicators Sales Value (%), (2020-2031)
 Figure 28. United States Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 29. United States Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 30. United States Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 31. Europe Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Europe Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 33. Europe Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 34. China Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 35. China Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 36. China Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 37. Japan Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 38. Japan Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 39. Japan Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 40. South Korea Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 41. South Korea Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 42. South Korea Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 43. Southeast Asia Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 45. Southeast Asia Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 46. India Biological Indicators Sales Value, (2020-2031) & (US$ Million)
 Figure 47. India Biological Indicators Sales Value by Type (%), 2024 VS 2031
 Figure 48. India Biological Indicators Sales Value by Application (%), 2024 VS 2031
 Figure 49. Biological Indicators Industrial Chain
 Figure 50. Biological Indicators Manufacturing Cost Structure
 Figure 51. Channels of Distribution (Direct Sales, and Distribution)
 Figure 52. Bottom-up and Top-down Approaches for This Report
 Figure 53. Data Triangulation
 Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Q6174
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Z4276
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8Q8325
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29V19536
Thu Sep 11 00:00:00 UTC 2025

Add to Cart